Both in Biotechnology
Acumen Pharmaceuticals vs aTyr Pharma
Over the past year ABOS returned −89.2% and ATYR returned −81.9%; their daily moves had a correlation of 0.06.
ABOS −89.2% ATYR −81.9%Growth of $1, one year, split-adjusted
| Metric | ABOS | ATYR |
|---|---|---|
| Price | $0.2102 | $5.97 |
| Market cap | $15.2M | $14.9M |
| Today | −2.82% | −3.40% |
| 1 month | −90.0% | −46.4% |
| 6 months | −91.5% | −83.8% |
| Year to date | −90.0% | −80.9% |
| 1 year | −89.2% | −81.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 78.6× |
| Net cash | $52.3M | $56.9M |
| Dividend yield | — | — |
| Volatility (60d) | 492.8% | 1,072.3% |
| Short % of float | 7.6% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).